DE69231384D1 - Zusammensetzungen zur behandlung des chronischen erschöpfungs-syndroms - Google Patents

Zusammensetzungen zur behandlung des chronischen erschöpfungs-syndroms

Info

Publication number
DE69231384D1
DE69231384D1 DE69231384T DE69231384T DE69231384D1 DE 69231384 D1 DE69231384 D1 DE 69231384D1 DE 69231384 T DE69231384 T DE 69231384T DE 69231384 T DE69231384 T DE 69231384T DE 69231384 D1 DE69231384 D1 DE 69231384D1
Authority
DE
Germany
Prior art keywords
syndrome
chronic
exhaust
compositions
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69231384T
Other languages
English (en)
Other versions
DE69231384T2 (de
Inventor
Peter Bridge
K Goodwin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
National Institutes of Health NIH
Original Assignee
US Department of Health and Human Services
National Institutes of Health NIH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, National Institutes of Health NIH filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE69231384D1 publication Critical patent/DE69231384D1/de
Publication of DE69231384T2 publication Critical patent/DE69231384T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69231384T 1991-05-08 1992-05-08 Zusammensetzungen zur behandlung des chronischen erschöpfungs-syndroms Expired - Fee Related DE69231384T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/696,556 US5189022A (en) 1988-05-27 1991-05-08 Composition for the treatment of chronic fatigue syndrome
PCT/US1992/003582 WO1992019257A1 (en) 1991-05-08 1992-05-08 Compositons for the treatment of chronic fatigue syndrome

Publications (2)

Publication Number Publication Date
DE69231384D1 true DE69231384D1 (de) 2000-09-28
DE69231384T2 DE69231384T2 (de) 2001-02-01

Family

ID=24797555

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69231384T Expired - Fee Related DE69231384T2 (de) 1991-05-08 1992-05-08 Zusammensetzungen zur behandlung des chronischen erschöpfungs-syndroms

Country Status (10)

Country Link
US (1) US5189022A (de)
EP (1) EP0584247B1 (de)
JP (1) JP3215110B2 (de)
AU (1) AU663875B2 (de)
CA (1) CA2102606C (de)
DE (1) DE69231384T2 (de)
DK (1) DK0584247T3 (de)
ES (1) ES2149177T3 (de)
GR (1) GR3034757T3 (de)
WO (1) WO1992019257A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739109A (en) * 1988-12-16 1998-04-14 Advanced Immunit Inc. Method of treating neuroinflammatory degenerative diseases
JPH05262654A (ja) * 1992-03-18 1993-10-12 Kaken Pharmaceut Co Ltd 慢性疲労症候群治療剤
US6011014A (en) * 1992-03-27 2000-01-04 Advanced Immunit, Inc. Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
PT960886E (pt) * 1992-03-27 2004-10-29 Advanced Immunit T Inc Peptido t e peptidos relacionados no tratamento de inflamacao; incluindo esclerose multipla
DE69433763T2 (de) * 1993-09-24 2005-04-14 Advanced Immuni T, Inc. Lineare und cyklische peptide zur behandlung oder verhinderung von ekzem und dermatitis
EP0729360B1 (de) * 1993-09-24 2004-05-26 Advanced Immuni T, Inc. Lineare und cyklische peptide zur behandlung oder vorbeugung der crohn'schen krankheit und/oder der ulzerativen kolitis
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6537997B1 (en) 1997-02-18 2003-03-25 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6399622B1 (en) 1997-02-18 2002-06-04 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US5872123A (en) 1997-02-18 1999-02-16 Lerner; A. Martin Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
ZA200800457B (en) * 2005-07-26 2009-08-26 Cms Peptides Patent Holding Co Novel biologically active peptides and their new uses
US20140100238A1 (en) 2012-10-04 2014-04-10 Ohio State University Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880626A (en) * 1985-01-18 1989-11-14 Mcmichael John Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
US5013739A (en) * 1986-10-07 1991-05-07 Bernard Bihari Method of treating chronic fatigue syndrome using an opiate receptor antagonist
DE68928752T2 (de) * 1988-05-27 1998-12-03 Us Health Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten
US5063206A (en) * 1988-12-16 1991-11-05 The United States Of Americas As Represented By The Department Of Health And Human Services Compositions having use as treatment of neuropsychiatric deficits

Also Published As

Publication number Publication date
AU2015292A (en) 1992-12-21
GR3034757T3 (en) 2001-02-28
DK0584247T3 (da) 2000-11-06
CA2102606C (en) 2003-02-11
EP0584247A1 (de) 1994-03-02
AU663875B2 (en) 1995-10-26
JPH06510749A (ja) 1994-12-01
DE69231384T2 (de) 2001-02-01
WO1992019257A1 (en) 1992-11-12
EP0584247B1 (de) 2000-08-23
CA2102606A1 (en) 1992-11-09
US5189022A (en) 1993-02-23
EP0584247A4 (en) 1994-09-14
JP3215110B2 (ja) 2001-10-02
ES2149177T3 (es) 2000-11-01

Similar Documents

Publication Publication Date Title
NO972002L (no) Synergistiske biocidale sammenblandinger
DE69716525T2 (de) Handgelenkstütze zur Behandlung des Karpaltunnelsyndroms
BR9200112A (pt) Composicoes cataliticas
FI941628A (fi) Seos verenvuodon tyrehdyttämiseksi paikallisesti
MA22840A1 (fr) Compositions nettoyantes.
DE58905201D1 (de) Mittel zur behandlung des parkinson-syndroms.
FI911196A (fi) Synergistiska soetningsompositioner.
KR930701276A (ko) 판석 톱
DE69310839T2 (de) Fungiresistente Polyorganosiloxanzusammensetzung
DE69231384D1 (de) Zusammensetzungen zur behandlung des chronischen erschöpfungs-syndroms
ITRM920869A0 (it) Medicamenti per trattare condizioni infiammatorie o per analgesia.
FI922688A0 (fi) Komposition foer uppfriskning av luft.
DE69204061T2 (de) Abgasfilter.
DE69327812D1 (de) Arsen-enthaltende arzneimittel zur behandlung des chronischen ermüdungssyndroms
DE69222233T2 (de) Halogen Scavenger Zusammensetzung
NO20010464D0 (no) Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom
DE69227337D1 (de) Copolyestercarbonat-Zusammensetzung
DE69225104D1 (de) PCT-Zusammensetzung
DE69104814D1 (de) Kandite Tonerdenzusammensetzungen.
FI934360A (fi) Synergistiska antimalariakompositioner innehaollande benflumetol
IT9022456A0 (it) Composizione sterilizzante
FI912642A (fi) Synergistiska soetningskompositioner.
DE69307136D1 (de) Anordnung zur thermischen behandlung.
KR920011480A (ko) 고혈압 치료제 조성물
DE3780448T2 (de) Zusammensetzungen zur behandlung der symptome oder zur verhuetung des schnupfens.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee